Clinical Trial Update: Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms

View source ↗

Summary

A clinical trial update on the Surpass Evolve Flow Diverter for intracranial aneurysms notes the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Surpass Evolve Flow Diverter

Snippet

Sponsor: Yibin Fang | Conditions: Intracranial Arterial Aneurysm | Status: ACTIVE_NOT_RECRUITING